[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:hepatobiliary-cancer":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":81,"states":82},"Hepatobiliary Cancer",12,[7,15,21,27,33,39,45,51,57,63,69,75],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT01174121","Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:15:53.461103Z","2026-05-05T02:43:29.157617Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT07039526","Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.",[11],"2026-08-26T02:17:33.807405Z","2026-05-05T02:43:26.932827Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT07399977","Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism",[],"2026-08-26T02:18:58.958025Z","2026-05-05T02:43:28.714239Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT05497531","Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers",[],"2026-08-26T02:17:58.890423Z","2026-05-05T02:43:28.639917Z",{"nct_id":34,"title":35,"phases":36,"status":12,"updated_at":37,"content_modified":38},"NCT03823144","Intravital Microscopy in Human Solid Tumors",[],"2026-08-26T02:16:24.135291Z","2026-05-05T02:43:26.953054Z",{"nct_id":40,"title":41,"phases":42,"status":12,"updated_at":43,"content_modified":44},"NCT06053333","Social Determinants of Health in Hepatobiliary Cancer Patients",[],"2026-08-26T02:15:27.567165Z","2026-05-13T02:55:06.403782Z",{"nct_id":46,"title":47,"phases":48,"status":12,"updated_at":49,"content_modified":50},"NCT06228209","Tier - Palliative Care For Patients With Advanced Heart Failure or Cancer",[],"2026-08-26T02:19:03.581490Z","2026-06-16T05:54:07.720102Z",{"nct_id":52,"title":53,"phases":54,"status":12,"updated_at":55,"content_modified":56},"NCT05366881","cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease",[],"2026-08-26T02:18:51.009190Z","2026-05-13T02:55:06.303581Z",{"nct_id":58,"title":59,"phases":60,"status":12,"updated_at":61,"content_modified":62},"NCT07124546","Acceptance and Commitment Therapy (ACT-HBC) for the Improvement of Cancer Distress in Patients With Hepatobiliary Cancers",[],"2026-08-26T02:17:03.534765Z","2026-05-05T02:43:27.093342Z",{"nct_id":64,"title":65,"phases":66,"status":12,"updated_at":67,"content_modified":68},"NCT06260943","Targeted Navigation in Hepatocellular Carcinoma (HCC)",[],"2026-08-26T02:18:12.612955Z","2026-05-05T02:35:31.674722Z",{"nct_id":70,"title":71,"phases":72,"status":12,"updated_at":73,"content_modified":74},"NCT06936878","BOLSTER: Learning New Skills to Thrive",[],"2026-08-26T02:15:57.572488Z","2026-05-05T02:43:29.535284Z",{"nct_id":76,"title":77,"phases":78,"status":12,"updated_at":79,"content_modified":80},"NCT06263088","EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.",[],"2026-08-26T02:19:04.543908Z","2026-05-05T02:43:27.634026Z",[],[83,87,90],{"state":84,"count":85,"slug":86},"Florida",3,"florida",{"state":88,"count":85,"slug":89},"Minnesota","minnesota",{"state":91,"count":85,"slug":92},"Texas","texas"]